AI assistant
Sending…
PULSE BIOSCIENCES, INC. — Director's Dealing 2019
Nov 19, 2019
32093_dirs_2019-11-19_c9c8682e-5125-4432-a882-e8b4d4dad0ca.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2019-11-18
Reporting Person: GARDINER SANDRA A. (CFO & EVP Admin. and Finance)
More from PULSE BIOSCIENCES, INC.
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 11
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 16
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Mar 17